Latin America Erythropoietin Drugs Market was worth USD 0.99 billion in 2018 and estimated to be growing at a CAGR of 9.87%, to reach USD 1.59 billion by 2023.
Erythropoietin is present in the bone marrow cells controlling the production of red blood cells. They can be used for the treatment of anaemia, HIV and Cancer. Various synthetic forms of erythropoietin are available in the market due to advancements in recombinant DNA technology.
